Reumatizam, Vol. 64 No. 2, 2017.
Pregledni rad
2017 RECOMMENDATION PROPOSAL OF THE CROATIAN SOCIETY OF RHEUMATOLOGY FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS WITH BIOLOGIC DRUGS AND TARGETED SYNTHETIC DRUGS
Joško Mitrović
Jadranka Morović-Vergles
Dušanka Martinović Kaliterna
Branimir Anić
Đurđica Babić-Naglić
Simeon Grazio
Frane Grubišić
Nadica Laktašić-Žerjavić
Nikolina Ljubičić Marković
Miroslav Mayer
Srđan Novak
Višnja Prus
Tea Schnurrer-Luke-Vrbanić
Tonko Vlak
Sažetak
Rheumatoid arthritis is a systemic infl ammatory rheumatic disease that primarily aff ects joints, but may also
aff ect inner organs, skin, as well as the sensory and nervous systems. Additionally, patients with rheumatoid arthritis
have an increased risk of cardiovascular diseases. Over the last years the approach to management of rheumatoid
arthritis has been signifi cantly changed. Early diagnosis as well as early onset of treatment with synthetic and biologic
disease-modifying antirheumatic drugs is now considered to be of utmost importance to prevent irreversible damage
in this serious illness.
Th e Croatian Rheumatological Society of the Croatian Medical Association has updated the recommendations for
management of rheumatoid arthritis in line with the most recent advances in the fi eld.
Ključne riječi
Arthritis, rheumatoid – diagnosis, drug therapy; Severity of illness index; Antirheumatic agents – therapeutic use; Biological products – therapeutic use; Biosimilar pharmaceuticals – therapeutic use; Tumor necrosis factor alpha – antagonists and inhibitors; Janus kinases – antagonists and inhibitors; Practice guidelines as topic; Croatia
Hrčak ID:
198809
URI
Datum izdavanja:
29.3.2018.
Posjeta: 2.718 *